Pulished Date August, 2019
ID: 584
Share on
Share on

Asia-Pacific Biopharmaceuticals Market By Product Type, By Therapeutic Type & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2019-2024)

Pulished: August, 2019
ID: 584
Pages: 145

APAC Biopharmaceuticals Market Size & Growth (2019 – 2024)

Asia-Pacific Biopharmaceuticals market was worth $36.57 billion in 2019 and estimated to be growing at a CAGR of 10.05%, to reach $59.03 billion by 2024.

The Asia Pacific is the third-largest pharmaceutical market in the world after North America and Europe. The major driver for the pharmaceutical industry in this region is generics, aided by factors such as the aging population and impending expiry of patented drugs.

Drivers and Restraints

Biopharmaceuticals are medical drugs that can either be produced by biotechnological techniques like recombinant DNA technology or from transgenic plants and animals that are genetically modified. Various diseases such as cancer, diabetes, rheumatoid arthritis, cardiovascular diseases, and chronic renal failure are being treated by biopharmaceutical drugs which were non-curable with earlier molecular drugs.

Major factors such as technological advancements in biopharmaceuticals, increasing geriatric population, increasing research and development investment and rising incidences of chronic diseases are propelling the market growth. In addition, the ability of biopharmaceuticals to approach a specific target with high efficiency helps in the treatment of various chronic diseases and disorders. However, the risk of side-effects and the high cost of biopharmaceuticals are restraining the growth of the market.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: Monoclonal Antibodies (mAb), Erythropoietin, Biotech Vaccines, Recombinant Human (RH) Insulin, Granulocyte Colony-stimulating Factor (G-CSF), Interferon And Human Growth Hormones (HGH)
  • By Therapeutic Type: Neurology, Infectious Diseases, Diabetes, Oncology, Cardiovascular, And Other Therapeutic Areas
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

China leads the market in this region due to the highest population.

The Top companies leading in the APAC Biopharmaceuticals market profiled in the report are:

Companies like,

  1. Merck & Co., Inc.
  2. F. Hoffmann-La Roche AG
  3. Eli Lilly and Company, Inc.
  4. Sanofi, Amgen Inc.
  5. AbbVie Inc.
  6. Biogen Idec
  7. Bayer AG
  8. Johnson & Johnson Services
  9. Pfizer, Inc.
  10. Novartis AG

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Product Type                       

                                5.1.1 Monoclonal Antibodies (mAb)       

                                5.1.2 Erythropoietin       

                                5.1.3 Biotech Vaccines  

                                5.1.4 Recombinant Human (RH) Insulin 

                                5.1.5 Granulocyte colony-stimulating factor (G-CSF)       

                                5.1.6 Interferon               

                                5.1.7 Human growth hormones (HGH)  

                5.2 By Therapeutic Type                               

                                5.2.1 Neurology               

                                5.2.2 Infectious diseases              

                                5.2.3 Diabetes  

                                5.2.4 Oncology 

                                5.2.5 Cardiovascular       

                                5.2.6 Other Therapeutic Areas  

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Merck & Co.                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 F. Hoffmann-La Roche AG                    

                8.3 Eli Lilly and Company                              

                8.4 Sanofi                           

                8.5 Amgen Inc.                 

                8.6 AbbVie Inc.                 

                8.7 Biogen Idec                

                8.8 Bayer AG                     

                8.9 Johnson & Johnson Services                               

                8.10 Pfizer                          

                8.11 Novartis AG                             

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Biopharmaceuticals market By Region, From 2019-2024 (USD Billion)
  2. Asia-Pacific Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  3. Asia-Pacific Monoclonal Antibodies (mAb) Market By Region, From 2019-2024 (USD Billion)
  4. Asia-Pacific Erythropoietin Market By Region, From 2019-2024 (USD Billion)
  5. Asia-Pacific Biotech Vaccines Market By Region, From 2019-2024 (USD Billion)
  6. Asia-Pacific Recombinant Human (RH) Insulin Market By Region, From 2019-2024 (USD Billion)
  7. Asia-Pacific Granulocyte colony-stimulating factor (G-CSF) Market By Region, From 2019-2024 (USD Billion)
  8. Asia-Pacific Interferon Market By Region, From 2019-2024 (USD Billion)
  9. Asia-Pacific Human growth hormones (HGH) Market By Region, From 2019-2024 (USD Billion)
  10. Asia-Pacific Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  11. Asia-Pacific Neurology Market By Region, From 2019-2024 (USD Billion)
  12. Asia-Pacific Infectious diseases Market By Region, From 2019-2024 (USD Billion)
  13. Asia-Pacific Diabetes Market By Region, From 2019-2024 (USD Billion)
  14. Asia-Pacific Oncology Market By Region, From 2019-2024 (USD Billion)
  15. Asia-Pacific Cardiovascular Market By Region, From 2019-2024 (USD Billion)
  16. Asia-Pacific Other Therapeutic Areas Market By Region, From 2019-2024 (USD Billion)
  17. China Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  18. China Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  19. India Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  20. India Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  21. Japan Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  22. Japan Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  23. South Korea Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  24. South Korea Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)
  25. Australia Biopharmaceuticals market By Product Type, From 2019-2024 (USD Billion)
  26. Australia Biopharmaceuticals market By Therapeutic Type, From 2019-2024 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample